IGF-I R/IGF1R Antibody (3G5C1) | Novus Biologicals NB110-87052 product information

product summary

company name :

Novus Biologicals

other brands :

IMGENEX

product type :

antibody

product name :

IGF-I R/IGF1R Antibody (3G5C1)

catalog :

NB110-87052

quantity :

0.1 ml (also 0.025 ml)

price :

409 USD

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

3G5C1

reactivity :

human

application :

western blot, ELISA, immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section

more info or order :

Novus Biologicals product webpage

citations: 15

Published Application/Species/Sample/Dilution	Reference
immunohistochemistry - paraffin section; human; 1:5000; tbl 2	Koo D, Lee H, Ahn J, Yoon D, Kim S, Gong G, et al. Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancer. Tumour Biol. 2015;36:5865-71 pubmed publisher
	De Martino M, van Koetsveld P, Feelders R, de Herder W, Dogan F, Janssen J, et al. IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer. Endocrine. 2019;64:673-684 pubmed publisher
	Wang H, Huang W, Yu X, Li W, Huang Y, Mo Z, et al. Two prostate cancer‑associated polymorphisms in the 3'UTR of IGF1R influences prostate cancer susceptibility by affecting miRNA binding. Oncol Rep. 2019;41:512-524 pubmed publisher
	Yong T, Chen S, Xie Y, Chen D, Su J, Shuai O, et al. Hypouricemic Effects of Armillaria mellea on Hyperuricemic Mice Regulated through OAT1 and CNT2. Am J Chin Med. 2018;46:585-599 pubmed publisher
	Yong T, Chen S, Xie Y, Chen D, Su J, Shuai O, et al. Cordycepin, a Characteristic Bioactive Constituent in Cordyceps militaris, Ameliorates Hyperuricemia through URAT1 in Hyperuricemic Mice. Front Microbiol. 2018;9:58 pubmed publisher
	Yong T, Chen S, Xie Y, Chen D, Su J, Shuai O, et al. Hypouricemic Effects of Ganoderma applanatum in Hyperuricemia Mice through OAT1 and GLUT9. Front Pharmacol. 2017;8:996 pubmed publisher
	Tomioka N, Tamura Y, Takada T, Shibata S, Suzuki H, Uchida S, et al. Immunohistochemical and in situ hybridization study of urate transporters GLUT9/URATv1, ABCG2, and URAT1 in the murine brain. Fluids Barriers CNS. 2016;13:22 pubmed
	Jori B, Kamps R, Xanthoulea S, Delvoux B, Blok M, Van de Vijver K, et al. Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients. Oncotarget. 2015;6:41108-22 pubmed publisher
	Jiwa L, van Diest P, Hoefnagel L, Wesseling J, Wesseling P, Moelans C. Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases. BMC Cancer. 2014;14:864 pubmed publisher
	Ceccom J, Loukh N, Lauwers Cances V, Touriol C, Nicaise Y, Gentil C, et al. Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease. Acta Neuropathol Commun. 2014;2:12 pubmed publisher
	Vermeulen J, van der Wall E, Witkamp A, van Diest P. Analysis of expression of membrane-bound tumor markers in ductal carcinoma in situ of the breast: paving the way for molecular imaging. Cell Oncol (Dordr). 2013;36:333-40 pubmed publisher
	Vermeulen J, Kornegoor R, van der Wall E, van der Groep P, van Diest P. Differential expression of growth factor receptors and membrane-bound tumor markers for imaging in male and female breast cancer. PLoS ONE. 2013;8:e53353 pubmed publisher
	Varewijck A, Brugts M, Frystyk J, Goudzwaard J, Uitterlinden P, Waaijers A, et al. Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling. Mol Cell Endocrinol. 2013;365:17-24 pubmed publisher
	Vermeulen J, van Brussel A, van der Groep P, Morsink F, Bult P, van der Wall E, et al. Immunophenotyping invasive breast cancer: paving the road for molecular imaging. BMC Cancer. 2012;12:240 pubmed publisher
	Kong K, Kwong D, Chan T, Law S, Chen L, Li Y, et al. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut. 2012;61:33-42 pubmed publisher

product information

master code :

NB110-87052

SKU :

NB110-87052

product name :

IGF-I R/IGF1R Antibody (3G5C1)

unit size :

0.1 ml (also 0.025 ml)

description :

The IGF-I R/IGF1R Antibody (3G5C1) from Novus is a mouse monoclonal antibody to IGF-I R/IGF1R. This antibody reacts with human. The IGF-I R/IGF1R Antibody (3G5C1) has been validated for the following applications: IF/IHC,Western Blot,Immunohistochemistry-Paraffin,ELISA,Immunohistochemistry.

target :

IGF-I R/IGF1R

category :

Primary Antibodies

buffer :

Ascites

clonality :

Monoclonal

clone :

3G5C1

conjugate :

Unconjugated

host :

Mouse

immunogen :

Purified recombinant fragment of IGF-I R/IGF1R (AA: 1101-1367) expressed in E. Coli.

isotype :

IgG2a

purity :

Unpurified

species :

Human

theoretical molecular weight :

96 kDa

gene symbol :

IGF1R

accessionNumbers :

P08069

applications :

IF/IHC,Western Blot,Immunohistochemistry-Paraffin,ELISA,Immunohistochemistry

USD :

409 USD

alt names :

CD221, CD221 antigen, EC 2.7.10, EC 2.7.10.1, IGF-I receptor, IGFIR, IGFR, insulin-like growth factor 1 receptor, Insulin-like growth factor I receptor, JTK13, MGC142170, MGC142172, MGC18216, soluble IGF1R variant 1, soluble IGF1R variant 2

storage :

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

more info or order :

Novus Biologicals product webpage